Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07352215Not ApplicableRecruiting

PRP Plus Fractional CO₂ Laser for Acne Scars

Role: lead

NCT07327983Not ApplicableCompleted

Azelaic Acid 20% vs Hydroquinone 4% in Epidermal Melasma

Role: lead

NCT05945797Not ApplicableCompleted

Effects of Dexamethasone on Common Bile Duct Cannulation Time

Role: lead

NCT06594276Not ApplicableRecruiting

Comparison of Efficacy in Treating Breast Abscess, With Systemic Antibiotics Against Local Instillation of Antibiotics Along With Ultrasound Guided Aspiration.

Role: lead

All 4 trials loaded